Literature DB >> 21769672

PDGF: the nuts and bolts of signalling toolbox.

Ammad Ahmad Farooqi1, Salman Waseem, Asma M Riaz, Bilal Ahmed Dilawar, Shahzeray Mukhtar, Sehrish Minhaj, Makhdoom Saad Waseem, Suneel Daniel, Beenish Ali Malik, Ali Nawaz, Shahzad Bhatti.   

Abstract

PDGF is a growth factor and is extensively involved in multi-dimensional cellular dynamics. It switches on a plethora of molecules other than its classical pathway. It is engaged in various transitions of development; however, if the unleashed potentials lead astray, it brings forth tumourigenesis. Conventionally, it has been assumed that the components of this signalling pathway show fidelity and act with a high degree of autonomy. However, as illustrated by the PDGF signal transduction, reinterpretation of recent data suggests that machinery is often shared between multiple pathways, and other components crosstalk to each other through multiple mechanisms. It is important to note that metastatic cascade is an intricate process that we have only begun to understand in recent years. Many of the early steps of this PDGF cascade are not readily targetable in the clinic. In this review, we will unravel the paradoxes with reference to mitrons and cellular plasticity and discuss how disruption of signalling cascade triggers cellular proliferation phase transition and metastasis. We will also focus on the therapeutic interventions to counteract resultant molecular disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21769672     DOI: 10.1007/s13277-011-0212-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  110 in total

1.  Assessing the activity of cediranib, a VEGFR-2/3 tyrosine kinase inhibitor, against VEGFR-1 and members of the structurally related PDGFR family.

Authors:  Sandra R Brave; Kirsty Ratcliffe; Zena Wilson; Neil H James; Sue Ashton; Anna Wainwright; Jane Kendrew; Philippa Dudley; Nicola Broadbent; Graham Sproat; Sian Taylor; Claire Barnes; Jeffrey C Silva; Charles L Farnsworth; Laurent Hennequin; Donald J Ogilvie; Juliane M Jürgensmeier; Masabumi Shibuya; Stephen R Wedge; Simon T Barry
Journal:  Mol Cancer Ther       Date:  2011-03-25       Impact factor: 6.261

2.  Pterostilbene, a natural dimethylated analog of resveratrol, inhibits rat aortic vascular smooth muscle cell proliferation by blocking Akt-dependent pathway.

Authors:  Eun-Seok Park; Yong Lim; Jin-Tae Hong; Hwan-Soo Yoo; Chong-Kil Lee; Myoung-Yun Pyo; Yeo-Pyo Yun
Journal:  Vascul Pharmacol       Date:  2010-04-14       Impact factor: 5.773

3.  Molecular cloning of gene sequences regulated by platelet-derived growth factor.

Authors:  B H Cochran; A C Reffel; C D Stiles
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

4.  Platelet-derived growth factor-D expression in developing and mature human kidneys.

Authors:  Siribha Changsirikulchai; Kelly L Hudkins; Tracy A Goodpaster; John Volpone; Stavros Topouzis; Debra G Gilbertson; Charles E Alpers
Journal:  Kidney Int       Date:  2002-12       Impact factor: 10.612

5.  PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation.

Authors:  Jessica Perez; Rebecca A Torres; Petra Rocic; Mary J Cismowski; David S Weber; Victor M Darley-Usmar; Pamela A Lucchesi
Journal:  Am J Physiol Cell Physiol       Date:  2011-03-30       Impact factor: 4.249

6.  Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models.

Authors:  Chunhua Lu; Mian M K Shahzad; Myrthala Moreno-Smith; Yvonne G Lin; Nicholas B Jennings; Julie K Allen; Charles N Landen; Lingegowda S Mangala; Guillermo N Armaiz-Pena; Rosemarie Schmandt; Alpa M Nick; Rebecca L Stone; Robert B Jaffe; Robert L Coleman; Anil K Sood
Journal:  Cancer Biol Ther       Date:  2010-02-16       Impact factor: 4.742

7.  miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.

Authors:  Dejuan Kong; Yiwei Li; Zhiwei Wang; Sanjeev Banerjee; Aamir Ahmad; Hyeong-Reh Choi Kim; Fazlul H Sarkar
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

8.  Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma.

Authors:  Kenneth L Pitter; Craig J Galbán; Stefanie Galbán; Omid Saeed Tehrani; Omid Saeed-Tehrani; Fei Li; Nikki Charles; Michelle S Bradbury; Oren J Becher; Thomas L Chenevert; Alnawaz Rehemtulla; Brian D Ross; Eric C Holland; Dolores Hambardzumyan
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240

9.  Actin-binding protein-1 interacts with WASp-interacting protein to regulate growth factor-induced dorsal ruffle formation.

Authors:  Christa L Cortesio; Benjamin J Perrin; David A Bennin; Anna Huttenlocher
Journal:  Mol Biol Cell       Date:  2009-11-12       Impact factor: 4.138

10.  Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancer.

Authors:  P Mathew; P F Thall; S Wen; C Bucana; D Jones; E Horne; W K Oh; M J Morris; Y-C Lee; C J Logothetis; S-H Lin; I J Fidler
Journal:  Br J Cancer       Date:  2008-10-07       Impact factor: 7.640

View more
  13 in total

Review 1.  Implementing neuronal plasticity in NeuroAIDS: the experience of brain-derived neurotrophic factor and other neurotrophic factors.

Authors:  Italo Mocchetti; Alessia Bachis; Lee A Campbell; Valeriya Avdoshina
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-06       Impact factor: 4.147

2.  Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma.

Authors:  Sirintip Boonjaraspinyo; Thidarut Boonmars; Zhiliang Wu; Watcharin Loilome; Paiboon Sithithaworn; Isao Nagano; Somchai Pinlaor; Puangrat Yongvanit; Phuangphaka Sadee Nielsen; Chawalit Pairojkul; Narong Khuntikeo
Journal:  Tumour Biol       Date:  2012-06-26

3.  PDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin.

Authors:  Sarah L Ondrejka; Armin G Jegalian; Annette S Kim; Devon S Chabot-Richards; Jennifer Giltnane; David R Czuchlewski; Shashirekha Shetty; Mikkael A Sekeres; Ashwini Yenamandra; David Head; Madan Jagasia; Eric D Hsi
Journal:  Haematologica       Date:  2014-06-20       Impact factor: 9.941

4.  VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patients.

Authors:  Sang Hoon Song; In Gab Jeong; Dalsan You; Jun Hyuk Hong; Bumsik Hong; Cheryn Song; Woon Yong Jung; Young Mee Cho; Hanjong Ahn; Choung-Soo Kim
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 5.  Rab23 activities and human cancer-emerging connections and mechanisms.

Authors:  Yanan Chen; Fanny Ng; Bor Luen Tang
Journal:  Tumour Biol       Date:  2016-07-23

6.  Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease.

Authors:  Cynthia A Moylan; Herbert Pang; Andrew Dellinger; Ayako Suzuki; Melanie E Garrett; Cynthia D Guy; Susan K Murphy; Allison E Ashley-Koch; Steve S Choi; Gregory A Michelotti; Daniel D Hampton; Yuping Chen; Hans L Tillmann; Michael A Hauser; Manal F Abdelmalek; Anna Mae Diehl
Journal:  Hepatology       Date:  2013-12-13       Impact factor: 17.425

7.  Inhibition of proliferation and migration of luminal and claudin-low breast cancer cells by PDGFR inhibitors.

Authors:  Leanne Stalker; James Pemberton; Roger A Moorehead
Journal:  Cancer Cell Int       Date:  2014-09-05       Impact factor: 5.722

Review 8.  Recent developments in receptor tyrosine kinases targeted anticancer therapy.

Authors:  Samir H Raval; Ratn D Singh; Dilip V Joshi; Hitesh B Patel; Shailesh K Mody
Journal:  Vet World       Date:  2016-01-29

9.  Tumor-induced osteomalacia due to a recurrent mesenchymal tumor overexpressing several growth factor receptors.

Authors:  Maria P Yavropoulou; Nikolina Gerothanasi; Athanasios Frydas; Evangelia Triantafyllou; Chris Poulios; Prodromos Hytiroglou; Panagiotis Apostolou; Ioannis Papasotiriou; Symeon Tournis; Isaak Kesisoglou; John G Yovos
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-05-27

10.  Combined inhibition of TGFβ and PDGF signaling attenuates radiation-induced pulmonary fibrosis.

Authors:  Monika Dadrich; Nils H Nicolay; Paul Flechsig; Sebastian Bickelhaupt; Line Hoeltgen; Falk Roeder; Kai Hauser; Alexandra Tietz; Jürgen Jenne; Ramon Lopez; Manuel Roehrich; Ute Wirkner; Michael Lahn; Peter E Huber
Journal:  Oncoimmunology       Date:  2015-12-29       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.